Raymond James & Associates’s Emeren Group SOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$97.2K Buy
+36,000
New +$67K ﹤0.01% 3785
2022
Q4
Sell
-18,489
Closed -$93K 4057
2022
Q3
$93K Sell
18,489
-5,117
-22% -$29.2K ﹤0.01% 3622
2022
Q2
$112K Buy
23,606
+317
+1% +$1.54K ﹤0.01% 3660
2022
Q1
$135K Buy
23,289
+5,885
+34% +$34.7K ﹤0.01% 3765
2021
Q4
$104K Buy
17,404
+914
+6% +$6.54K ﹤0.01% 3854
2021
Q3
$108K Buy
+16,490
New +$118K ﹤0.01% 3823
2021
Q2
Sell
-54,684
Closed -$674K 4195
2021
Q1
$674K Buy
+54,684
New +$998K ﹤0.01% 2788

Other funds holding SOL

Raymond James & Associates's SOL Position: Q3 2024 in Review

Raymond James & Associates opened a new position in Emeren Group (SOL) in Q3 2024: 36,000 shares worth $97.2K. The stake represents ﹤0.01% of the portfolio and ranks #3785 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in SOL as recently as Q3 2022.

Raymond James & Associates first reported a position in SOL in Q1 2021 and has held it in 7 quarters since. The position peaked at $674K in Q1 2021. 42 funds tracked by Wall St. Rank hold SOL as of Q3 2024.

  • Raymond James & Associates held 36,000 shares of Emeren Group worth $97.2K as of Q3 2024.
  • Emeren Group was a new Raymond James & Associates position in Q3 2024.
  • Emeren Group made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3785 holding.
  • Raymond James & Associates first reported a position in Emeren Group in Q1 2021 and has held it in 7 quarters since.
  • Raymond James & Associates's Emeren Group position peaked at $674K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Emeren Group as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.